MDXH is under dual Nasdaq deficiency notices (bid price and MVLS) with a market cap 37% below the $35M threshold. The stock faces acute delisting risk. Traders should monitor for any reverse stock split announcement, capital raise, or business development that could boost market value. Absent a catalyst, the path to compliance appears challenging, and the stock may continue to drift lower.
Price Chart
Executive Summary
MDxHealth received a second Nasdaq deficiency notice on July 20, 2026, for failing to maintain a minimum Market Value of Listed Securities (MVLS) of $35 million, following a prior bid price non-compliance notice on July 2. The company now faces two concurrent listing deficiencies and has until January 19, 2027, to cure the MVLS issue. With a market cap of only $22M—well below the $35M threshold—the risk of eventual delisting is elevated, which would severely impair the company's ability to raise capital.
Key Facts
- MDxHealth received a second Nasdaq deficiency notice on July 20, 2026, for non-compliance with the $35 million minimum MVLS requirement (Rule 5550(b)(2)).
- The company's market cap is approximately $22 million, far below the $35 million threshold.
- The company has 180 calendar days, until January 19, 2027, to regain compliance by achieving MVLS of at least $35 million for 10 consecutive business days.
- This follows a prior notice on July 2, 2026, for non-compliance with the $1.00 minimum bid price requirement (Rule 5550(a)(2)).
- Failure to regain compliance could result in delisting from Nasdaq, which would materially and adversely affect the company's ability to raise capital.
- The company states its business operations are not affected by the notice and intends to monitor its market value and cure the deficiency.
Financial Impact
Market cap of ~$22M is $13M below the $35M MVLS threshold; delisting risk threatens capital access for a company already in distress.
Risk Factors
- Failure to regain MVLS compliance by January 19, 2027, could lead to delisting from Nasdaq.
- The company may need to execute a reverse stock split or raise dilutive capital to address the bid price deficiency, further pressuring the stock.
- The company's ability to raise capital is materially and adversely affected by the non-compliance and potential delisting.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (MDXH) — Batch item 1 | 0001213900-26-081499 |
| Document: ea029861501ex99-1.htm | 0001213900-26-081499 |
| Document: 0001213900-26-081499-index-headers.html | 0001213900-26-081499 |
| Document: 0001213900-26-081499-index.html | 0001213900-26-081499 |
| Document: 0001213900-26-081499.txt | 0001213900-26-081499 |
| 6-K Filing (MDXH) — Batch item 6 | 0001213900-26-081499 |
| Document: ea029861501ex99-1.htm | 0001213900-26-081499 |
| Document: 0001213900-26-081499-index-headers.html | 0001213900-26-081499 |
| Document: 0001213900-26-081499-index.html | 0001213900-26-081499 |
| Document: 0001213900-26-081499.txt | 0001213900-26-081499 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 6-K | $0.2070 $0.1830 | ▲ +11.59% | ▲ +11.69% | $0.1970 (+4.83%) |
Oct 15, 2026 12d ago | SC 13D/A | $0.2066 $0.1833 | ▲ +11.28% | ▲ +10.85% | $0.1970 (+4.65%) |
Oct 15, 2026 12d ago | Press Release | $0.2066 $0.1833 | ▲ +11.28% | ▲ +10.85% | $0.1970 (+4.65%) |
Sep 17, 2026 5w ago | 144 | $0.6300 $0.5650 | ▲ +10.32% | ▲ +11.59% | $0.1970 (+68.73%) |
Sep 3, 2026 7w ago | 6-K | $0.7484 $0.7072 | ▲ +5.51% | ▲ +4.30% | $0.1970 (+73.68%) |
Aug 13, 2026 10w ago | 6-K | $0.8080 $0.7431 | ▲ +8.03% | ▲ +6.66% | $0.1970 (+75.62%) |
Aug 13, 2026 10w ago | Press Release | $0.8080 $0.7431 | ▼ −8.03% | ▼ −6.66% | $0.1970 (−75.62%) |
Jul 24, 2026 13w ago | 6-K | $0.4180 $0.4180 | · 0.00% | ▲ +1.07% | $0.1970 (+52.87%) |
Jul 2, 2026 16w ago | Press Release | $0.4765 $0.4899 | ▼ −2.81% | ▼ −1.88% | $0.1970 (+58.66%) |
Apr 29, 2026 25w ago | 6-K | $2.04 $2.01 | ▼ −1.47% | ▼ −3.20% | $0.1970 (−90.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers